Long intergenic non-protein coding RNA 2343 (LINC02343)

Long intergenic non-protein coding RNA 2343 (LINC02343) is a human long intergenic non-coding RNA (lincRNA) gene transcript that exceeds 200 nucleotides in length and does not overlap annotated protein-coding genes [1][3][7]. LINC02343, like other lincRNAs, likely plays roles in regulating gene expression through diverse mechanisms such as influencing chromatin structure, modulating the transcription of neighboring genes, and potentially acting as an enhancer RNA [3][5][7]. While other lincRNAs have been characterized as key regulators in processes like cell differentiation, proliferation, and chromatin organization, there are currently no published functional or disease-specific studies directly implicating LINC02343 in therapeutic targeting, disease biomarker use, or safety concern contexts [1][3][7]. This RNA belongs to a large class of regulatory RNAs whose broad, tissue-specific impact on transcriptional programs is an ongoing area of research [3][7]. Interpretation and Limitations: - LINC02343 is not considered a therapeutic target in the classical sense (not a receptor, enzyme, transporter, or transcription factor), nor does it have assigned drugs or defined biomarker roles at present [1][3]. - Specific biological or disease roles for LINC02343 are not described in available literature or major databases as of now [1]. - Its functional properties are inferred from established characteristics of long intergenic non-coding RNAs in general, not LINC02343 specifically [3][7].

Other names

LINC02343